Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Corvatta

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Future Oncology (London, England)|November 2, 2017
A review discussing elotuzumab and its use in the second-line plus treatment of multiple myelomaMassimo Offidani, Laura Corvatta
British Journal of Haematology|December 21, 2022
Maintenance therapy in multiple myeloma: Two is not always better than oneMassimo Offidani, Sonia Morè, Laura Corvatta
Expert Opinion on Pharmacotherapy|December 22, 2017
Triplet vs. doublet drug regimens for managing multiple myelomaMassimo Offidani, Laura Corvatta, Silvia Gentili
Drug Design, Development and Therapy|June 9, 2021
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and SafetyMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Journal of Experimental Pharmacology|March 17, 2021
Novel Experimental Drugs for Treatment of Multiple MyelomaMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Cancers|May 16, 2023
Current Main Topics in Multiple MyelomaSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Expert Review of Anticancer Therapy|November 22, 2015
Oral ixazomib maintenance therapy in multiple myelomaMassimo Offidani, Laura Corvatta, Silvia Gentili, et al.
Cancers|June 10, 2023
Belantamab Mafodotin: From Clinical Trials Data to Real-Life ExperiencesSonia Morè, Massimo Offidani, Laura Corvatta, et al.
Cancers|June 27, 2024
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications ManagementSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
British Journal of Haematology|January 17, 2023
Real-world assessment of treatment patterns and outcomes in patients with relapsed-refractory multiple myeloma in an Italian haematological tertiary care centreSonia Morè, Laura Corvatta, Maria Valentina Manieri, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Future Oncology (London, England)|November 2, 2017
A review discussing elotuzumab and its use in the second-line plus treatment of multiple myelomaMassimo Offidani, Laura Corvatta
British Journal of Haematology|December 21, 2022
Maintenance therapy in multiple myeloma: Two is not always better than oneMassimo Offidani, Sonia Morè, Laura Corvatta
Expert Opinion on Pharmacotherapy|December 22, 2017
Triplet vs. doublet drug regimens for managing multiple myelomaMassimo Offidani, Laura Corvatta, Silvia Gentili
Drug Design, Development and Therapy|June 9, 2021
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and SafetyMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Journal of Experimental Pharmacology|March 17, 2021
Novel Experimental Drugs for Treatment of Multiple MyelomaMassimo Offidani, Laura Corvatta, Sonia Morè, et al.
Cancers|May 16, 2023
Current Main Topics in Multiple MyelomaSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
Expert Review of Anticancer Therapy|November 22, 2015
Oral ixazomib maintenance therapy in multiple myelomaMassimo Offidani, Laura Corvatta, Silvia Gentili, et al.
Cancers|June 10, 2023
Belantamab Mafodotin: From Clinical Trials Data to Real-Life ExperiencesSonia Morè, Massimo Offidani, Laura Corvatta, et al.
Cancers|June 27, 2024
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications ManagementSonia Morè, Laura Corvatta, Valentina Maria Manieri, et al.
British Journal of Haematology|January 17, 2023
Real-world assessment of treatment patterns and outcomes in patients with relapsed-refractory multiple myeloma in an Italian haematological tertiary care centreSonia Morè, Laura Corvatta, Maria Valentina Manieri, et al.
Pageof 5